Noggin suppression decreases BMP-2-induced osteogenesis of human bone marrow-derived mesenchymal stem cells in vitro

J Cell Biochem. 2012 Dec;113(12):3672-80. doi: 10.1002/jcb.24240.

Abstract

Numerous studies with rodent cells and animal models indicate that noggin inhibits osteogenesis by antagonizing bone morphogenetic proteins (BMPs); however, the effect of noggin on osteogenesis of human cells remains ambiguous. This study aims to examine the effects of noggin suppression on viability and BMP-2-induced osteogenic differentiation of human bone marrow-derived mesenchymal stem cells (MSCs) in vitro. Noggin expression in human MSCs was suppressed by noggin-specific small interfering RNA (siRNA), and viability of human MSCs was determined by measuring the mitochondrial dehydrogenase activity, cellular DNA content and protein amount. The BMP-2-induced osteogenic differentiation of human MSCs was assessed by analyzing the expression levels of several osteoblastic genes, enzymatic alkaline phosphatase (ALP) activity and calcification. Our study showed that noggin suppression significantly decreased human MSC metabolism and DNA content on Days 3 and 6, and decreased total protein amount on Day 14. Noggin suppression also reduced the expression levels of osteoblastic genes, ALP, integrin-binding sialoprotein (IBSP), muscle segment homeobox gene (MSX2), osteocalcin (OC), osteopontin (OPN), and runt-related transcription factor-2 (RUNX2). Significantly decreased enzymatic ALP activity in noggin-suppressed group was evident. Moreover, noggin suppression decreased calcium deposits by BMP-2-induced osteoblasts. Collectively, this study showed that noggin suppression decreased viability and BMP-2-induced osteogenic differentiation of human MSCs, which suggests that noggin is stimulatory to osteogenesis of human MSCs.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alkaline Phosphatase / genetics
  • Alkaline Phosphatase / metabolism
  • Bone Marrow / metabolism*
  • Bone Morphogenetic Protein 2 / metabolism
  • Bone Morphogenetic Protein 2 / pharmacology*
  • Calcification, Physiologic
  • Carrier Proteins / genetics
  • Carrier Proteins / metabolism*
  • Cell Differentiation
  • Cell Survival
  • Cells, Cultured
  • Core Binding Factor Alpha 1 Subunit / genetics
  • Core Binding Factor Alpha 1 Subunit / metabolism
  • DNA / analysis
  • DNA / metabolism
  • Dose-Response Relationship, Drug
  • Enzyme Activation
  • Gene Expression Regulation
  • Homeodomain Proteins / genetics
  • Homeodomain Proteins / metabolism
  • Humans
  • Integrin-Binding Sialoprotein / genetics
  • Integrin-Binding Sialoprotein / metabolism
  • Mesenchymal Stem Cells / cytology
  • Mesenchymal Stem Cells / drug effects*
  • Mesenchymal Stem Cells / metabolism
  • Osteocalcin / genetics
  • Osteocalcin / metabolism
  • Osteogenesis*
  • Osteopontin / genetics
  • Osteopontin / metabolism
  • RNA, Small Interfering / genetics
  • RNA, Small Interfering / metabolism
  • Recombinant Proteins / pharmacology
  • Time Factors
  • Transfection

Substances

  • BMP2 protein, human
  • Bone Morphogenetic Protein 2
  • Carrier Proteins
  • Core Binding Factor Alpha 1 Subunit
  • Homeodomain Proteins
  • IBSP protein, human
  • Integrin-Binding Sialoprotein
  • MSX2 protein
  • RNA, Small Interfering
  • RUNX2 protein, human
  • Recombinant Proteins
  • Osteocalcin
  • Osteopontin
  • noggin protein
  • DNA
  • Alkaline Phosphatase